SCHEMBL2732935

SCHEMBL2732935

C=C(Cc1ccc(-c2ccc(CC(=C)C(=O)O)cc2)cc1)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.54
ABCC4 O15439 1/20 0.54
GAA P10253 1/20 0.54
TSHR P16473 1/20 0.54
PTGS1 P23219 1/20 0.54
HTT P42858 1/20 0.54
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
ALDH1A1 P00352 3/20 0.43
RXRA P19793 3/20 0.42
RXRB P28702 3/20 0.42
RXRG P48443 3/20 0.42
CA2 P00918 1/20 0.41
CAMK2A Q9UQM7 1/20 0.41
SRD5A2 P31213 1/20 0.41
FFAR1 O14842 2/20 0.41
HPGD P15428 1/20 0.41
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
AKR1B1 P15121 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL36672 0.94 LMNA (0.64) LMNAABCC4GAATSHRPTGS1
SCHEMBL3426193 0.93 CA2 (0.46) LMNAABCC4GAATSHRPTGS1
Hydrochloric Acid SCHEMBL8692226 0.92 LMNA (0.62) LMNAABCC4GAATSHRPTGS1
SCHEMBL4808967 0.90 CTBP2 (0.51) LMNAABCC4GAATSHRPTGS1
SCHEMBL4806417 0.90 CTBP2 (0.51) LMNAABCC4GAATSHRPTGS1
SCHEMBL4805934 0.90 HAO1 (0.46) LMNAABCC4GAATSHRPTGS1
SCHEMBL4801218 0.87 MAPT (0.53) LMNAABCC4GAATSHRPTGS1
SCHEMBL4797444 0.86 RXRA (0.55) LMNAABCC4GAATSHRPTGS1
SCHEMBL83884 0.84 CA2 (0.61) LMNACA2CAMK2A
SCHEMBL41907 0.84 CES1 (0.58) LMNAABCC4GAATSHRPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118684822-A Packaging composition, application thereof and display device 武汉尚赛光电科技有限公司 2024-09-24 CN disclosed
CN-110300919-B Liquid crystal display device having a plurality of pixel electrodes DIC株式会社 2022-07-01 CN disclosed
EP-3257916-B1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2021-11-17 EP disclosed
US-20210277310-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2021-09-09 US disclosed
CN-105814480-B Liquid crystal display device having a plurality of pixel electrodes DIC株式会社 2020-01-07 CN disclosed
US-20180119010-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2018-05-03 US disclosed
EP-3260518-A1 LIQUID CRYSTALLINE MEDIUM Merck Patent GmbH (DE) 2017-12-27 EP disclosed
EP-3257916-A1 LIQUID CRYSTALLINE MEDIUM Merck Patent GmbH (DE) 2017-12-20 EP disclosed
EP-2691490-B1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2017-07-26 EP disclosed
EP-2243812-B2 Liquid crystal display MERCK PATENT GMBH (DE) 2016-09-07 EP disclosed
EP-2243812-B1 Liquid crystal display MERCK PATENT GMBH (DE) 2012-06-13 EP disclosed
US-20110255048-A1 LIQUID-CRYSTAL DISPLAY MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2011-10-20 US disclosed
US-20100272925-A1 LIQUID-CRYSTAL DISPLAY MERCK PATENT GESELLSCHAFT (DE) 2010-10-28 US disclosed
EP-2243812-A2 Liquid crystal display Merck Patent GmbH (DE) 2010-10-27 EP disclosed
US-6982181-B2 Manufacturing process for ultra slim electrooptic display device unit SONY CORPORATION (JP) 2006-01-03 US disclosed
US-20050266591-A1 Manufacturing process for ultra slim electrooptic display device unit SONY CORPORATION 2005-12-01 US disclosed
US-6844905-B2 Alignment film, method for fabricating the alignment film, liquid crystal device, and projection type display device SEIKO EPSON CORPORATION (JP) 2005-01-18 US disclosed
US-20040259326-A1 Manufacturing process for ultra slim electrooptic display device unit SONY CORPORATION (JP) 2004-12-23 US disclosed
US-20040080685-A1 Alignment film, method for fabricating the alignment film, liquid crystal device, and projection type display device SEIKO EPSON CORPORATION (JP) 2004-04-29 US disclosed
US-4366171-A Fungicidal biphenyl esters, mixtures thereof and method of use GAF CORPORATION (US) 1982-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110255048-A1 LIQUID-CRYSTAL DISPLAY KLK3, BPHL, LPXN LMNA 1528/4885ABCC4 4782/4885GAA 3807/4885
US-20100272925-A1 LIQUID-CRYSTAL DISPLAY KLK3, BPHL, LPXN LMNA 974/4885ABCC4 4723/4885GAA 2796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.